Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Multicenter Validation of a Privacy-Preserving OCR-LLM Pipeline for Four-Subtype Coronary Syndrome Classification Using Admission HPI Across Heterogeneous EHR Systems

NCT07449429 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT07449429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07449429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Multicenter Validation of a Privacy-Preserving OCR-LLM Pipeline for Four-Subtype Coronary Syndrome Classification Using Admission HPI Across Heterogeneous EHR Systems
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
March 8, 2026
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd)), non-st-segment elevation myocardial infarction (nstemi), st-segment elevation myocardial infarction (stemi)